Clinical Trials Directory

Trials / Unknown

UnknownNCT04853706

Validation of the 3D-CAM Turkish Version

Validation of the 3D-CAM Turkish Version in Surgical ICU Patients

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
245 (estimated)
Sponsor
Aydin Adnan Menderes University · Academic / Other
Sex
All
Age
65 Years
Healthy volunteers
Not accepted

Summary

3D CAM into Turkish validity and reliability on postoperative delirium will be test as a prospective diagnostic study. After approval by Dr. Edward R. Marcantonio, (15) will translation and back-translation. The original 3D-CAM will translate into Turkish by two medical doctor .The two translational versions will be discussed and merged into a final version. Back translation will performed in regardless of any information from its original version by another two medical doctor. Both the translated and back translated versions will sent to Dr. Marcantonio for approval. Eligibility and the documentation of consent will be confirmed at the preoperative visit. During this visit, patients will provide demographic and historical medical information, including information regarding medication usage. The Mini-Mental State Exam (MMSE) will be performed. Delirium assessment Delirium assessment with the 3D-CAM Before the study period, all researchers will participate online training program on 3D CAM. Delirium will be evaluated using the 3D CAM every each morning and evening (18:00-20:00) for postoperative 3 days. Delirium assessment with the DSM-5 The psychiatrist investigator who was blinded to the 3D-CAM assessment results, will evaluate the patients according to the criteria of DSM-5 within 3 min after the 3D-CAM assessment.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TEST3d camThe 3D-CAM is a short interview that uses verbal responses and allows completion of the Confusion Assessment Method (CAM) diagnostic algorithm
DIAGNOSTIC_TESTDSM 5The DSM-5 is the gold standard for diagnosing delirium. But proper use requires professional psychiatric background and training.

Timeline

Start date
2021-04-18
Primary completion
2021-10-18
Completion
2021-12-18
First posted
2021-04-21
Last updated
2021-04-21

Source: ClinicalTrials.gov record NCT04853706. Inclusion in this directory is not an endorsement.